SS Innovations International (NASDAQ:SSII) Announces Quarterly Earnings Results

SS Innovations International (NASDAQ:SSII) released its earnings results on Wednesday. The company reported ($0.02) earnings per share for the quarter, FiscalAI reports. The firm had revenue of $11.10 million during the quarter. SS Innovations International had a negative net margin of 28.54% and a negative return on equity of 30.23%.

SS Innovations International Stock Performance

Shares of NASDAQ:SSII traded down $0.08 during trading hours on Thursday, reaching $3.91. The stock had a trading volume of 58,228 shares, compared to its average volume of 77,828. SS Innovations International has a 1 year low of $3.02 and a 1 year high of $11.87. The firm’s 50 day moving average is $4.61 and its 200-day moving average is $5.32. The stock has a market capitalization of $782.51 million and a price-to-earnings ratio of -65.17.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on SSII shares. Wall Street Zen cut shares of SS Innovations International from a “hold” rating to a “sell” rating in a report on Saturday, May 2nd. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of SS Innovations International in a research report on Tuesday, April 21st. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

Insider Transactions at SS Innovations International

In other news, Director Frederic H. Moll bought 501,253 shares of the stock in a transaction that occurred on Friday, March 6th. The stock was purchased at an average price of $3.99 per share, for a total transaction of $1,999,999.47. Following the completion of the purchase, the director owned 10,775,485 shares in the company, valued at approximately $42,994,185.15. This trade represents a 4.88% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Srivastava Sudhir bought 498,753 shares of the company’s stock in a transaction that occurred on Friday, March 6th. The stock was acquired at an average cost of $4.01 per share, for a total transaction of $1,999,999.53. Following the acquisition, the chief executive officer directly owned 109,851,767 shares of the company’s stock, valued at $440,505,585.67. The trade was a 0.46% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last three months, insiders bought 1,300,006 shares of company stock valued at $5,196,999.

Institutional Investors Weigh In On SS Innovations International

Several institutional investors have recently added to or reduced their stakes in SSII. Inspire Investing LLC boosted its holdings in SS Innovations International by 26.4% in the first quarter. Inspire Investing LLC now owns 104,624 shares of the company’s stock valued at $523,000 after purchasing an additional 21,851 shares in the last quarter. IFC & Insurance Marketing Inc. raised its holdings in SS Innovations International by 47.7% during the first quarter. IFC & Insurance Marketing Inc. now owns 16,730 shares of the company’s stock worth $84,000 after purchasing an additional 5,400 shares in the last quarter. Eversept Partners LP purchased a new stake in shares of SS Innovations International during the 4th quarter worth approximately $428,000. Vontobel Holding Ltd. acquired a new position in shares of SS Innovations International in the 4th quarter valued at $116,000. Finally, Jane Street Group LLC acquired a new position in shares of SS Innovations International in the 4th quarter valued at $63,000.

About SS Innovations International

AVRA Medical Robotics, Inc develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc and changed its name to AVRA Medical Robotics, Inc in November 2015. AVRA Medical Robotics, Inc was founded in 2015 and is based in Orlando, Florida.